For respondents facing novel Federal Trade Commission theories, the lesson is that early engagement—not reflexive litigation—can yield outcomes that address regulatory concerns while preserving ...

Nation's largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers.

The FTC’s newly announced settlement with Express Scripts marks a pivotal moment in the government’s campaign against ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

President Donald Trump late Thursday unveiled TrumpRx, a direct-to-consumer website where Americans can buy prescription drugs directly from drugmakers at reduced prices. But the initiative, pitched ...

TrumpRx, the Trump administration's much-anticipated direct-to-consumer drug platform, went live on Thursday. A key pillar of President Donald Trump's effort to lower prescription drug costs, the ...

WASHINGTON – The Federal Trade Commission (FTC) has secured a landmark settlement with one of the nation’s largest pharmacy benefit managers (PBMs), Express Scripts, Inc., and its affiliated entities ...

Cigna's top brass said that the company has anticipated a "clearing event" in the pharmacy benefit management industry, and that its new model aligns with regulators' push toward greater transparency.

WASHINGTON - Federal regulators announced a settlement Wednesday with Express Scripts to change how the company handles prescription drug pricing. The agreement aims to lower out-of-pocket costs for ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...